Mark Robertson-Tessi
Mark Robertson-Tessi
Verified email at moffitt.org - Homepage
Title
Cited by
Cited by
Year
Impact of metabolic heterogeneity on tumor growth, invasion, and treatment outcomes
M Robertson-Tessi, RJ Gillies, RA Gatenby, ARA Anderson
Cancer research 75 (8), 1567-1579, 2015
1782015
A mathematical model of tumor–immune interactions
M Robertson-Tessi, A El-Kareh, A Goriely
Journal of theoretical biology 294, 56-73, 2012
962012
Defining cancer subpopulations by adaptive strategies rather than molecular properties provides novel insights into intratumoral evolution
A Ibrahim-Hashim, M Robertson-Tessi, PM Enriquez-Navas, M Damaghi, ...
Cancer research 77 (9), 2242-2254, 2017
772017
Abscopal benefits of localized radiotherapy depend on activated T-cell trafficking and distribution between metastatic lesions
JT Poleszczuk, KA Luddy, S Prokopiou, M Robertson-Tessi, EG Moros, ...
Cancer research 76 (5), 1009-1018, 2016
742016
Elastic growth models
A Goriely, M Robertson-Tessi, M Tabor, R Vandiver
Mathematical modelling of biosystems, 1-44, 2008
742008
The role of toll-like receptors in colorectal cancer progression: evidence for epithelial to leucocytic transition
KA Luddy, M Robertson-Tessi, NK Tafreshi, H Soliman, DL Morse
Frontiers in immunology 5, 429, 2014
352014
Recombination line versus forbidden line abundances in planetary nebulae
M Robertson-Tessi, DR Garnett
The Astrophysical Journal Supplement Series 157 (2), 371, 2005
282005
Stochasticity in the genotype-phenotype map: implications for the robustness and persistence of bet-hedging
D Nichol, M Robertson-Tessi, P Jeavons, ARA Anderson
Genetics 204 (4), 1523-1539, 2016
262016
Acidity promotes tumour progression by altering macrophage phenotype in prostate cancer
A El-Kenawi, C Gatenbee, M Robertson-Tessi, R Bravo, J Dhillon, ...
British journal of cancer, 1-11, 2019
242019
Big Bang and context-driven collapse
M Robertson-Tessi, ARA Anderson
Nature genetics 47 (3), 196-197, 2015
222015
A model for effects of adaptive immunity on tumor response to chemotherapy and chemoimmunotherapy
M Robertson-Tessi, A El-Kareh, A Goriely
Journal of theoretical biology 380, 569-584, 2015
162015
The immune checkpoint kick start: Optimization of neoadjuvant combination therapy using game theory
J West, M Robertson-Tessi, K Luddy, DS Park, DFK Williamson, ...
JCO clinical cancer informatics 3, 1-12, 2019
142019
Hybrid Automata Library: A flexible platform for hybrid modeling with real-time visualization
RR Bravo, E Baratchart, J West, RO Schenck, AK Miller, J Gallaher, ...
PLoS computational biology 16 (3), e1007635, 2020
13*2020
The goldilocks window of personalized chemotherapy: Getting the immune response just right
DS Park, M Robertson-Tessi, KA Luddy, PK Maini, MB Bonsall, ...
Cancer research 79 (20), 5302-5315, 2019
102019
Systematic screening of chemokines to identify candidates to model and create ectopic lymph node structures for cancer immunotherapy
Y Yagawa, M Robertson-Tessi, SL Zhou, ARA Anderson, JJ MulÚ, ...
Scientific Reports 7 (1), 1-16, 2017
92017
Evolutionary dynamics of neoantigens in growing tumors
E Lakatos, MJ Williams, RO Schenck, WCH Cross, J Househam, L Zapata, ...
Nature Genetics 52 (10), 1057-1066, 2020
82020
Cleaning silicon nitride gratings with liquid immersion
M Robertson-Tessi, RJ Wild, AD Cronin, T Savas
Journal of Vacuum Science & Technology B: Microelectronics and Nanometerá…, 2006
42006
Turnover modulates the need for a cost of resistance in adaptive therapy
MAR Strobl, J West, Y Viossat, M Damaghi, M Robertson-Tessi, J Brown, ...
BioRxiv, 2020
32020
Model genotype–phenotype mappings and the algorithmic structure of evolution
D Nichol, M Robertson-Tessi, ARA Anderson, P Jeavons
Journal of the Royal Society Interface 16 (160), 20190332, 2019
32019
Niche engineering drives early passage through an immune bottleneck in progression to colorectal cancer
CD Gatenbee, AM Baker, RO Schenck, MP Neves, SY Hasan, P Martinez, ...
bioRxiv, 623959, 2019
32019
The system can't perform the operation now. Try again later.
Articles 1–20